sulfaphenazole has been researched along with Chronic Disease in 3 studies
Sulfaphenazole: A sulfonilamide anti-infective agent.
sulfaphenazole : A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naik, JS | 1 |
| Walker, BR | 1 |
| Fischer, D | 1 |
| Landmesser, U | 1 |
| Spiekermann, S | 1 |
| Hilfiker-Kleiner, D | 1 |
| Hospely, M | 1 |
| Müller, M | 1 |
| Busse, R | 1 |
| Fleming, I | 1 |
| Drexler, H | 1 |
| Goslings, WR | 1 |
| Djajadiningrat, RJ | 1 |
| Bergstein, PG | 1 |
| Holle, P | 1 |
1 trial available for sulfaphenazole and Chronic Disease
| Article | Year |
|---|---|
Continuous suppressive antimicrobial treatment in chronic infected bronchitis during the winter months.
Topics: Bronchitis; Chronic Disease; Haemophilus influenzae; Humans; Influenza, Human; Placebos; Seasons; St | 1967 |
2 other studies available for sulfaphenazole and Chronic Disease
| Article | Year |
|---|---|
Role of vascular heme oxygenase in reduced myogenic reactivity following chronic hypoxia.
Topics: Animals; Anti-Infective Agents; Chronic Disease; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Sy | 2006 |
Cytochrome P450 2C9 is involved in flow-dependent vasodilation of peripheral conduit arteries in healthy subjects and in patients with chronic heart failure.
Topics: Aged; Anti-Infective Agents; Arteries; Aryl Hydrocarbon Hydroxylases; Chronic Disease; Cytochrome P- | 2007 |